Dag Heldal

  • Senior consultant; MD
  • +47 23 07 02 94
 

Publications 2020

Grønvold B, Ali MM, Remberger M, Mattsson J, Egeland T, Lundin KU, Myhre AE, Abrahamsen IW, Heldal D, Dybedal I, Tjønnfjord GE, Fløisand Y, Gedde-Dahl T (2020)
HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation
Bone Marrow Transplant, 55 (8), 1658-1661
DOI 10.1038/s41409-020-0827-3, PubMed 32054997

Remberger M, Grønvold B, Ali M, Mattsson J, Egeland T, Lundin KU, Myhre A, Abrahamsen I, Heldal D, Dybedal I, Tjønnfjord GE, Gedde-Dahl T, Fløisand Y (2020)
The CD34+ Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors
Clin Hematol Int, 2 (2), 74-81
DOI 10.2991/chi.d.200221.001, PubMed 34595446

Publications 2017

Pahnke S, Larfors G, Axdorph-Nygell U, Fischer-Nielsen A, Haastrup E, Heldal D, Itälä-Remes M, Johansson JE, Kauppila M, Lenhoff S, Ljungman P, Niittyvuopio R, Sandstedt A, Hägglund H (2017)
Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors
J Clin Apher, 33 (3), 226-235
DOI 10.1002/jca.21576, PubMed 28833474

Publications 2014

Bruserud Ø, Tvedt TH, Paulsen PQ, Ahmed AB, Gedde-Dahl T, Tjønnfjord GE, Slåstad H, Heldal D, Reikvam H (2014)
Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies
Cancer Immunol Immunother, 63 (8), 757-77
DOI 10.1007/s00262-014-1578-z, PubMed 24997173

Husøy MA, Brinch L, Tjønnfjord GE, Gedde-Dahl T, Heldal D, Holme PA, Dybedal I, Kolstad A, Akkök ÇA, Rollag H, Gaustad P, Bergan S, Egeland T, Josefsen D, Kvalheim G, Fløisand Y (2014)
[Allogeneic stem-cell transplantation in adults 1985-2012: results and development]
Tidsskr Nor Laegeforen, 134 (16), 1569-75
DOI 10.4045/tidsskr.13.1415, PubMed 25178233

Kristiansen HA, Spetalen S, Fløisand Y, Heldal D (2014)
Eltrombopag in Good's Syndrome
Case Rep Hematol, 2014, 172139
DOI 10.1155/2014/172139, PubMed 25389501

Publications 2013

Fløisand Y, Beiske K, Tjønnfjord GE, Heldal D, Bjerkehagen B, Revheim ME, Heim S, Bruland OS, Hall KS, Tierens A, Delabie J (2013)
Malignant phyllodes tumor and acute megakaryoblastic leukemia sharing a common clonal origin
Case Rep Hematol, 2013, 934781
DOI 10.1155/2013/934781, PubMed 24455338

Publications 2012

Fløisand Y, Brinch L, Gedde-Dahl T, Tjønnfjord GE, Dybedal I, Holte H, Heldal D, Torfoss D, Aurlien E, Lauritzsen GF, Fosså A, Lehne G, Baggerød E, Kvalheim G, Egeland T, Bishop MR, Fowler DH, Kolstad A (2012)
Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation
Bone Marrow Transplant, 47 (12), 1552-7
DOI 10.1038/bmt.2012.63, PubMed 22522568

Publications 2008

Brinch L, Tjønnfjord G, Gedde-Dahl T, Heldal D, Holme PA, Dybedal I (2008)
[Allogeneic stem cell transplantation in acute myelogenous leukemia]
Tidsskr Nor Laegeforen, 128 (15), 1681-2; author reply 1682
PubMed 18704137

Fløisand Y, Brinch L, Dybedal I, Gedde-Dahl T, Heldal D, Holme PA, Egeland T, Tjønnfjord GE (2008)
[Allogeneic stem cell transplantation in adults with acute lymphoblastic leukaemia]
Tidsskr Nor Laegeforen, 128 (22), 2563-6
PubMed 19023351

Publications 2007

Tjønnfjord GE, Gedde-Dahl T, Heldal D, Brinch L (2007)
Treatment outcome in adults with acute lymphoblastic leukemia: 50% long-term disease-free survival
Leukemia, 21 (10), 2203-4
DOI 10.1038/sj.leu.2404751, PubMed 17525727

Publications 2005

Abrahamsen IW, Sømme S, Heldal D, Egeland T, Kvale D, Tjønnfjord GE (2005)
Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease
Haematologica, 90 (1), 86-93
PubMed 15642674

Publications 2004

Heldal D (2004)
Allogeneic transplantation with stem cells from blood
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 231, 1 b. (flere pag.)
BIBSYS 042300320, ISBN 82-8072-168-1

Heldal D, Brinch L, Evensen SA, Tjønnfjord GE, Aamodt G, Elgjo K, Sviland L (2004)
Skin biopsies for early diagnosis and prognosis of graft-versus-host disease in recipients of allogeneic stem cells from blood or bone marrow
Bone Marrow Transplant, 34 (4), 345-50
DOI 10.1038/sj.bmt.1704568, PubMed 15170163

Publications 2003

Heldal D, Brinch L, Tjønnfjord G, Solheim BG, Egeland T, Albrechtsen D, Aamodt G, Evensen SA (2003)
Fewer relapses and increased chronic GVHD in patients transplanted with blood stem cells: a 5-year follow-up in a single centre study
Bone Marrow Transplant, 32 (3), 257-64
DOI 10.1038/sj.bmt.1704127, PubMed 12858196

Publications 2002

Ghanima W, Heldal D, Tjønnfjord GE (2002)
[Hairy cell leukemia treated with cladribine]
Tidsskr Nor Laegeforen, 122 (11), 1094-7
PubMed 12043051

Heldal D, Brinch L, Tjønnfjord G, Solheim BG, Egeland T, Gadeholt G, Albrechtsen D, Aamodt G, Evensen SA (2002)
Donation of stem cells from blood or bone marrow: results of a randomised study of safety and complaints
Bone Marrow Transplant, 29 (6), 479-86
DOI 10.1038/sj.bmt.1703418, PubMed 11960266

Publications 2000

Heldal D, Tjønnfjord G, Brinch L, Albrechtsen D, Egeland T, Steen R, Solheim BG, Evensen SA (2000)
A randomised study of allogeneic transplantation with stem cells from blood or bone marrow
Bone Marrow Transplant, 25 (11), 1129-36
DOI 10.1038/sj.bmt.1702422, PubMed 10849524

Publications 1997

Steen R, Tjønnfjord GE, Gunnes Grøseth LA, Heldal D, Egeland T (1997)
Efflux of CD34+ cells from bone marrow to peripheral blood is selective in steady-state hematopoiesis and during G-CSF administration
J Hematother, 6 (6), 563-73
DOI 10.1089/scd.1.1997.6.563, PubMed 9483191

Publications 1995

Juliusson G, Heldal D, Hippe E, Hedenus M, Malm C, Wallman K, Stolt CM, Evensen SA, Albertioni F, Tjønnfjord G (1995)
Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia
J Clin Oncol, 13 (4), 989-95
DOI 10.1200/JCO.1995.13.4.989, PubMed 7707128

Juliusson G, Lenkei R, Tjønnfjord G, Heldal D, Liliemark J (1995)
Neutropenic fever following cladribine therapy for symptomatic hairy-cell leukemia: predictive factors and effects of granulocyte-macrophage colony-stimulating factor
Ann Oncol, 6 (4), 371-5
DOI 10.1093/oxfordjournals.annonc.a059186, PubMed 7619752

Juliusson G, Lenkei R, Tjønnfjord G, Heldal D, Liliemark J (1995)
Low-dose cladribine for symptomatic hairy cell leukaemia
Br J Haematol, 89 (3), 637-9
DOI 10.1111/j.1365-2141.1995.tb08377.x, PubMed 7734367

Publications 1994

Heldal D, Tjønnfjord GE, Evensen SA, Juliusson G (1994)
[Progress in the treatment of hairy cell leukemia. Subcutaneous administration of 2-chloro-deoxy-adenosine for 7 days]
Tidsskr Nor Laegeforen, 114 (7), 800-3
PubMed 7912011

Publications 1992

Heldal D, Offstad J, Aksnes EG, Onstad A (1992)
[Cardiopulmonary resuscitation performed by laymen--the Nord-Gudbrandsdal Project--circulatory arrest in sparsely populated regions]
Tidsskr Nor Laegeforen, 112 (22), 2869-71
PubMed 1412329

Offstad J, Heldal D, Aksnes EG, Onstad A (1992)
[Results of treatment--the Nord-Gudbrandsdal Project--circulatory collapse in sparsely populated regions]
Tidsskr Nor Laegeforen, 112 (22), 2874-8
PubMed 1412330

Page visits: 8641